MedTrace Logo

Transmasculine Quality of Life and Sexual Function at Pre and Post Gender-affirming Hormonal Therapy

NCT06482385 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2024-07-01

No results posted yet for this study

Summary

The goal of this prospective observational study is to evaluate the short-term effect of testosterone therapy on these issues among hormone naïve TM individuals.

The main questions that aim to answer are :

1. Comparison quality of life in transgender men at pre and post testosterone therapy
2. To evaluate the most affected domain of quality of life (QOL) and FSFI of this participants

Participants will be ask to complete two questionnaires: the World Health Organization Quality of Life BREF THAI (WHO-QOL-BREF-THAI) and the FSFI (female sexual function index) before testosterone administration and both questionnaires will be re-evaluated at 12 weeks after initiation of testosterone therapy

Conditions

  • Transgender Men

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Vichadet Vichuladda, M.D. · Chulalongkorn University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-15
Primary Completion
2024-05-31
Completion
2024-05-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06482385 on ClinicalTrials.gov